Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells.
暂无分享,去创建一个
Petr Ježek | Rodrigue Rossignol | K. Smolková | P. Ježek | R. Rossignol | N. Bellance | Katarína Smolková | Lydie Plecitá-Hlavatá | Nadége Bellance | Giovanni Benard | L. Plecitá-Hlavatá | G. Bénard
[1] D. Tuveson,et al. Modelling oncogenic Ras/Raf signalling in the mouse. , 2009, Current opinion in genetics & development.
[2] H. Lenz. Colon cancer stem cells: a new target in the war against cancer. , 2008, Gastrointestinal cancer research : GCR.
[3] Alexander V. Zhdanov,et al. PGC-1α is coupled to HIF-1α-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells , 2009, Proceedings of the National Academy of Sciences.
[5] R. Deberardinis,et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation , 2005, Oncogene.
[6] C. Moraes,et al. Mitochondrial biogenesis and turnover. , 2008, Cell calcium.
[7] B. Halliwell,et al. Human skin keloid fibroblasts display bioenergetics of cancer cells. , 2008, The Journal of investigative dermatology.
[8] K. Smolková,et al. Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development. , 2010, The international journal of biochemistry & cell biology.
[9] Russell G. Jones,et al. Tumor suppressors and cell metabolism: a recipe for cancer growth. , 2009, Genes & development.
[10] Nicola Zamboni,et al. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells , 2007, The Journal of cell biology.
[11] Chi V. Dang,et al. The interplay between MYC and HIF in cancer , 2008, Nature Reviews Cancer.
[12] J. Pouysségur,et al. A Dialogue between the Hypoxia-Inducible Factor and the Tumor Microenvironment , 2008, Cancer Microenvironment.
[13] J. P. McCoy,et al. The Mammalian Target of Rapamycin (mTOR) Pathway Regulates Mitochondrial Oxygen Consumption and Oxidative Capacity* , 2006, Journal of Biological Chemistry.
[14] G. Watkins,et al. The localisation and reduction of nuclear staining of PPARgamma and PGC-1 in human breast cancer. , 2004, Oncology reports.
[15] P. Assumpção,et al. MYC and gastric adenocarcinoma carcinogenesis. , 2008, World journal of gastroenterology.
[16] Ru Wei,et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.
[17] S. Ropero,et al. Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Ortega,et al. Glucose avidity of carcinomas. , 2009, Cancer letters.
[19] A. Krainer,et al. The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism , 2010, Proceedings of the National Academy of Sciences.
[20] A. Galinier,et al. Physiological diversity of mitochondrial oxidative phosphorylation. , 2006, American journal of physiology. Cell physiology.
[21] T. Arnould,et al. Mitochondrial biogenesis in mtDNA‐depleted cells involves a Ca2+‐dependent pathway and a reduced mitochondrial protein import , 2005, The FEBS journal.
[22] F. Kuhajda. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. , 2000, Nutrition.
[23] Daniel J Klionsky,et al. The Atg8 and Atg12 ubiquitin‐like conjugation systems in macroautophagy , 2008, EMBO reports.
[24] Howard Y. Chang,et al. MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species. , 2006, Cancer research.
[25] H. R. Zielke,et al. Glutamine: a major energy source for cultured mammalian cells. , 1984, Federation proceedings.
[26] Oksana Gavrilova,et al. p53 Regulates Mitochondrial Respiration , 2006, Science.
[27] I. Prior,et al. Compartmentalized signalling: Ras proteins and signalling nanoclusters , 2009, The FEBS journal.
[28] P. Puigserver,et al. Metabolic adaptations through the PGC‐1α and SIRT1 pathways , 2008 .
[29] A. Yalçin,et al. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. , 2009, Experimental and molecular pathology.
[30] B. Hoffman,et al. Apoptotic signaling by c-MYC , 2008, Oncogene.
[31] Keshav K. Singh,et al. Mitochondrial impairment in p53-deficient human cancer cells. , 2003, Mutagenesis.
[32] Ulrich Müller,et al. Mutations in SDHC cause autosomal dominant paraganglioma, type 3 , 2000, Nature Genetics.
[33] D. Simeone,et al. Pancreatic cancer stem cells. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] S. Emr,et al. Ubiquitin-Dependent Sorting into the Multivesicular Body Pathway Requires the Function of a Conserved Endosomal Protein Sorting Complex, ESCRT-I , 2001, Cell.
[35] S. Weinhouse. Isozyme alterations, gene regulation and the neoplastic transformation. , 1983, Advances in enzyme regulation.
[36] R A Jungmann,et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[37] Z. Elazar,et al. Oxidation as a Post-Translational Modification that Regulates Autophagy , 2007, Autophagy.
[38] R. Xavier,et al. Identification of Atg5-dependent transcriptional changes and increases in mitochondrial mass in Atg5-deficient T lymphocytes , 2009, Autophagy.
[39] P. Ježek,et al. Mitochondrial reticulum network dynamics in relation to oxidative stress, redox regulation, and hypoxia. , 2009, The international journal of biochemistry & cell biology.
[40] C. Lelliott,et al. Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. , 2003, The Biochemical journal.
[41] J. Menéndez,et al. The tyrosine kinase receptor HER2 (erbB‐2): From oncogenesis to adipogenesis , 2008, Journal of cellular biochemistry.
[42] N. Koitabashi,et al. Competitive Binding of CREB and ATF2 to cAMP/ATF Responsive Element Regulates eNOS Gene Expression in Endothelial Cells , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[43] J. Hayashi,et al. Enhanced glycolysis induced by mtDNA mutations does not regulate metastasis , 2008, FEBS letters.
[44] L. Reitzer,et al. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.
[45] W. Kaelin. The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer , 2008, Nature Reviews Cancer.
[46] E. Gnaiger,et al. Anaerobic metabolism in aerobic mammalian cells: information from the ratio of calorimetric heat flux and respirometric oxygen flux. , 1990, Biochimica et biophysica acta.
[47] A. Giatromanolaki,et al. Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer , 2005, Clinical & Experimental Metastasis.
[48] V Clower Cynthia,et al. 選択的スプライシングレプレッサーhnRNP A1/A2とPTBはピルビン酸キナーゼアイソフォーム発現と細胞代謝に影響する , 2010 .
[49] S. Jackowski,et al. Activity of the phosphatidylcholine biosynthetic pathway modulates the distribution of fatty acids into glycerolipids in proliferating cells. , 2000, Biochimica et biophysica acta.
[50] W. Linehan,et al. LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer , 2009, Molecular Cancer Therapeutics.
[51] Jiandie D. Lin,et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. , 2005, Cell metabolism.
[52] J. Settleman,et al. Isoform-specific ras functions in development and cancer. , 2009, Future oncology.
[53] Michael Höckel,et al. Oxygenation gain factor: a novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers. , 2003, Cancer research.
[54] Emma Saavedra,et al. Energy metabolism in tumor cells , 2007, The FEBS journal.
[55] M. Dalakas,et al. Mitochondrial myopathy caused by long-term zidovudine therapy. , 1990, The New England journal of medicine.
[56] Min Wu,et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy , 2008, The EMBO journal.
[57] J. Hoek,et al. Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. , 2005, Cancer research.
[58] Simon C Watkins,et al. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. , 2007, The American journal of pathology.
[59] R. Youle,et al. The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division , 2007, The Journal of cell biology.
[60] E. Gottlieb,et al. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.
[61] M. Yaffe,et al. A Role for Ubiquitination in Mitochondrial Inheritance in Saccharomyces cerevisiae , 1999, The Journal of cell biology.
[62] S. Dimauro,et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. , 1989, The New England journal of medicine.
[63] J. Ghysdael,et al. Expression of the v-src or v-fps oncogene increases fructose 2,6-bisphosphate in chick-embryo fibroblasts. Novel mechanism for the stimulation of glycolysis by retroviruses. , 1986, The Biochemical journal.
[64] J. M. Izquierdo,et al. A Conserved Mechanism for Controlling the Translation of β-F1-ATPase mRNA between the Fetal Liver and Cancer Cells* , 2000, The Journal of Biological Chemistry.
[65] Walter Pfaller,et al. Impact of Culture Conditions, Culture Media Volumes, and Glucose Content on Metabolic Properties of Renal Epithelial Cell Cultures , 1999, Cellular Physiology and Biochemistry.
[66] G. Arismendi-Morillo. Electron microscopy morphology of the mitochondrial network in human cancer. , 2009, The international journal of biochemistry & cell biology.
[67] M. Ausserlechner,et al. Isotype‐specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation , 2008, International journal of cancer.
[68] G. Wahl,et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. , 2002, Molecular cell.
[69] Lilia Alberghina,et al. Expression of transforming K-Ras oncogene affects mitochondrial function and morphology in mouse fibroblasts. , 2006, Biochimica et biophysica acta.
[70] E. Génot,et al. Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia , 2010, Journal of bioenergetics and biomembranes.
[71] Jiandie D. Lin,et al. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres , 2002, Nature.
[72] N. Hamasaki,et al. Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. , 2007, Mitochondrion.
[73] Marta Cascante,et al. K-ras Codon-Specific Mutations Produce Distinctive Metabolic Phenotypes in Human Fibroblasts , 2005 .
[74] P. Acebo,et al. Cancer abolishes the tissue type-specific differences in the phenotype of energetic metabolism. , 2009, Translational oncology.
[75] J. Teckman,et al. Mitochondrial autophagy and injury in the liver in α1-antitrypsin deficiency , 2004 .
[76] Tomoyuki Suzuki,et al. Up‐regulation of Na+,K+‐ATPase α3‐isoform and down‐regulation of the α1‐isoform in human colorectal cancer , 2004 .
[77] Mohamed H. Sayegh,et al. Identification of cells initiating human melanomas , 2008, Nature.
[78] C. Gustafsson,et al. Mitochondrial transcription and its regulation in mammalian cells. , 2007, Trends in biochemical sciences.
[79] C. Lelliott,et al. Mitochondrial Fusion Is Increased by the Nuclear Coactivator PGC-1β , 2008, PloS one.
[80] Richard P. Hill,et al. The hypoxic tumour microenvironment and metastatic progression , 2004, Clinical & Experimental Metastasis.
[81] Peng Huang,et al. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism , 2006, The Journal of cell biology.
[82] Rodrigue Rossignol,et al. Energy Substrate Modulates Mitochondrial Structure and Oxidative Capacity in Cancer Cells , 2004, Cancer Research.
[83] Mark W. Dewhirst,et al. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response , 2008, Nature Reviews Cancer.
[84] C. Dang,et al. MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities , 2009, Clinical Cancer Research.
[85] V. E. Price,et al. Anemia in cancer. , 1958, Advances in cancer research.
[86] G. Arismendi-Morillo,et al. Biological : Full-length Ultrastructural mitochondrial pathology in human astrocytic tumors : potentials implications pro-therapeutics strategies , 2008 .
[87] R. Scarpulla. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. , 2008, Physiological reviews.
[88] G. Semenza,et al. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. , 2007, Cancer cell.
[89] P. Vaupel,et al. Tumor hypoxia and malignant progression. , 2009, Methods in enzymology.
[90] Peter Vaupel,et al. Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. , 2008, The oncologist.
[91] M. Guppy,et al. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. , 1993, European journal of biochemistry.
[92] F. Saad. Src as a therapeutic target in men with prostate cancer and bone metastases , 2009, BJU international.
[93] K. Smolková,et al. Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacity. , 2009, The international journal of biochemistry & cell biology.
[94] A. Chatterjee,et al. Mitochondrial DNA mutations in human cancer , 2006, Oncogene.
[95] F. Bosch,et al. Evidence from transgenic mice that myc regulates hepatic glycolysis , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[96] I. Hassinen,et al. Inhibition of Hypoxia-inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates , 2007, Journal of Biological Chemistry.
[97] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[98] R. Deberardinis,et al. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. , 2007, Genes & development.
[99] D. Rapaport,et al. Biogenesis of mitochondrial outer membrane proteins. , 2009, Biochimica et biophysica acta.
[100] P. Pedersen,et al. Contributions of glycolysis and oxidative phosphorylation to adenosine 5'-triphosphate production in AS-30D hepatoma cells. , 1984, Cancer research.
[101] P. Pedersen,et al. Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen , 2007, Journal of bioenergetics and biomembranes.
[102] R. Minami,et al. Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features. , 2001, European journal of cancer.
[103] Marc Dellian,et al. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[104] H. Lyng,et al. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis , 2000, British Journal of Cancer.
[105] E. Espinosa,et al. HuR and the bioenergetic signature of breast cancer: a low tumor expression of the RNA-binding protein predicts a higher risk of disease recurrence. , 2008, Carcinogenesis.
[106] A. Alavi,et al. Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.
[107] John L Cleveland,et al. Myc pathways provoking cell suicide and cancer , 2003, Oncogene.
[108] A. Giatromanolaki,et al. PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer , 2008, British Journal of Cancer.
[109] P. Vaupel. Prognostic potential of the pre-therapeutic tumor oxygenation status. , 2009, Advances in experimental medicine and biology.
[110] E. Rofstad,et al. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. , 2005, Cancer research.
[111] M. Rigoulet,et al. Mitochondrial Oxidative Phosphorylation Is Regulated by Fructose 1,6-Bisphosphate , 2008, Journal of Biological Chemistry.
[112] Marty C. Brandon,et al. Mitochondrial mutations in cancer , 2006, Oncogene.
[113] P. Puigserver,et al. GCN5-mediated Transcriptional Control of the Metabolic Coactivator PGC-1β through Lysine Acetylation* , 2009, The Journal of Biological Chemistry.
[114] H. R. Zielke,et al. Growth of human diploid fibroblasts in the absence of glucose utilization. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[115] R. Moreno-Sánchez,et al. The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells? , 2009, BioFactors.
[116] J. M. Izquierdo,et al. Mitochondrial Biogenesis in the Liver during Development and Oncogenesis , 1997, Journal of bioenergetics and biomembranes.
[117] Daniel J Klionsky,et al. Eating the endoplasmic reticulum: quality control by autophagy. , 2007, Trends in cell biology.
[118] A. Maitra,et al. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck , 2007, Proceedings of the National Academy of Sciences.
[119] Kathy Pfeiffer,et al. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. , 2002, Carcinogenesis.
[120] M. Cole,et al. Mechanism of transcriptional activation by the Myc oncoproteins. , 2006, Seminars in cancer biology.
[121] J. Auwerx,et al. Transcriptional coregulators in the control of energy homeostasis. , 2007, Trends in cell biology.
[122] M. Dewhirst,et al. Temporal changes in PO2 of R3230AC tumors in Fischer-344 rats. , 1998, International journal of radiation oncology, biology, physics.
[123] M. Patel,et al. Regulation of the pyruvate dehydrogenase complex. , 2006, Biochemical Society transactions.
[124] J. Ingwall. Energy metabolism in heart failure and remodelling. , 2008, Cardiovascular research.
[125] A. Ortega,et al. The tumor suppressor function of mitochondria: translation into the clinics. , 2009, Biochimica et biophysica acta.
[126] J. Hayashi,et al. ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis , 2008, Science.
[127] Robert A. Harris,et al. Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer Cells* , 2008, Journal of Biological Chemistry.
[128] Chad E Jones,et al. Stimulation of mitochondrial biogenesis and autophagy by lipopolysaccharide in the neonatal rat cardiomyocyte protects against programmed cell death. , 2008, Journal of molecular and cellular cardiology.
[129] R. Scarpulla,et al. Nuclear Control of Respiratory Chain Expression by Nuclear Respiratory Factors and PGC‐1‐Related Coactivator , 2008, Annals of the New York Academy of Sciences.
[130] Wei Gu,et al. Modes of p53 Regulation , 2009, Cell.
[131] J. Troppmair,et al. Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism. , 2007, Anticancer research.
[132] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[133] E. Clementi,et al. Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxide , 2003, Science.
[134] N. Denko,et al. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.
[135] G. Schatten,et al. Development: Ubiquitin tag for sperm mitochondria , 1999, Nature.
[136] L. Korotchkina,et al. The biochemistry of the pyruvate dehydrogenase complex * , 2003 .
[137] C. Abbadie,et al. Senescent keratinocytes die by autophagic programmed cell death. , 2009, The American journal of pathology.
[138] John C Reed,et al. The bioenergetic signature of cancer: a marker of tumor progression. , 2002, Cancer research.
[139] Min Wu,et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. , 2007, American journal of physiology. Cell physiology.
[140] P. Leder,et al. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.
[141] R. Moreno-Sánchez,et al. Multisite control of the Crabtree effect in ascites hepatoma cells. , 2001, European journal of biochemistry.
[142] H. Moch,et al. Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL , 2003, Nature.
[143] D. Klionsky,et al. Autophagy and Vacuole Homeostasis: A Case for Self-Degradation? , 2007, Autophagy.
[144] V. Mootha,et al. Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.
[145] P. Vaupel,et al. Blood supply, oxygenation status and metabolic micromilieu of breast cancers: characterization and therapeutic relevance. , 2000, International journal of oncology.
[146] P. Puigserver,et al. Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.
[147] Yidong Bai,et al. Number matters: control of mammalian mitochondrial DNA copy number. , 2009, Journal of genetics and genomics = Yi chuan xue bao.
[148] V. Young,et al. Glutamine: the emperor or his clothes? , 2001, The Journal of nutrition.
[149] E. Gottlieb,et al. Cell-Permeating α-Ketoglutarate Derivatives Alleviate Pseudohypoxia in Succinate Dehydrogenase-Deficient Cells , 2007, Molecular and Cellular Biology.
[150] K. Pfeiffer,et al. Mitochondrial complex I is deficient in renal oncocytomas. , 2003, Carcinogenesis.
[151] R. F. Melo,et al. Occurrence of the Crabtree effect in HeLa cells , 1998, Cell biochemistry and function.
[152] D. Green,et al. Cytoplasmic functions of the tumour suppressor p53 , 2009, Nature.
[153] B. Spiegelman. Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. , 2007, Novartis Foundation symposium.
[154] T. Cotter,et al. Mechanisms of ROS modulated cell survival during carcinogenesis. , 2008, Cancer letters.
[155] B. Ebert,et al. Regulation of Transcription by Hypoxia Requires a Multiprotein Complex That Includes Hypoxia-Inducible Factor 1, an Adjacent Transcription Factor, and p300/CREB Binding Protein , 1998, Molecular and Cellular Biology.
[156] K. Vousden,et al. Modulation of intracellular ROS levels by TIGAR controls autophagy , 2009, The EMBO journal.
[157] P. Puigserver,et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity , 2009, Nature.
[158] M. Yuneva. Finding an “Achilles’ heel” of cancer: The role of glucose and glutamine metabolism in the survival of transformed cells , 2008, Cell cycle.
[159] R. Deberardinis,et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.
[160] R. Franklin,et al. Tumor cell metabolism: the marriage of molecular genetics and proteomics with cellular intermediary metabolism; proceed with caution! , 2006, Molecular Cancer.
[161] L G Strauss,et al. The applications of PET in clinical oncology. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[162] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[163] Emilio Clementi,et al. Calorie Restriction Promotes Mitochondrial Biogenesis by Inducing the Expression of eNOS , 2005, Science.
[164] C. Thompson,et al. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. , 2007, Cancer cell.
[165] Y. Yoon,et al. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[166] R. Shaw,et al. Glucose metabolism and cancer. , 2006, Current opinion in cell biology.
[167] Jonghwan Kim,et al. Global Identification of Myc Target Genes Reveals Its Direct Role in Mitochondrial Biogenesis and Its E-Box Usage In Vivo , 2008, PloS one.
[168] Michael Höckel,et al. Detection and characterization of tumor hypoxia using pO2 histography. , 2007, Antioxidants & redox signaling.
[169] N. Isern,et al. c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry , 2009, Oncogene.
[170] Fionnuala Morrish,et al. c-MYC apoptotic function is mediated by NRF-1 target genes. , 2003, Genes & development.
[171] P. Bénit,et al. S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. , 2007, Cell metabolism.
[172] R. Wiesner,et al. Clonal expansion of different mtDNA variants without selective advantage in solid tumors. , 2009, Mutation research.
[173] R. Parchment,et al. The Biological Basis of Cancer: Oncology: The difficult task of eradicating caricatures of normal tissue renewal in the human patient , 2006 .
[174] F. López-Ríos,et al. Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. , 2007, Cancer research.
[175] S. Rodríguez-Enríquez,et al. Selective degradation of mitochondria by mitophagy. , 2007, Archives of biochemistry and biophysics.
[176] Nektarios Tavernarakis,et al. Functional and physical interaction between Bcl‐XL and a BH3‐like domain in Beclin‐1 , 2007, The EMBO journal.
[177] Y. Mo,et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. , 2008, Cancer research.
[178] M. Lenardo,et al. The selectivity of autophagy and its role in cell death and survival , 2008, Autophagy.
[179] Robert J. Gillies,et al. A microenvironmental model of carcinogenesis , 2008, Nature Reviews Cancer.
[180] Daniel E Bauer,et al. ATP citrate lyase inhibition can suppress tumor cell growth. , 2005, Cancer cell.
[181] D. Hardie,et al. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy , 2007, Nature Reviews Molecular Cell Biology.
[182] P. Puigserver,et al. The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1α , 2008, Proceedings of the National Academy of Sciences.
[183] H. Kole,et al. Regulation of 6-phosphofructo-1-kinase activity in ras-transformed rat-1 fibroblasts. , 1991, Archives of biochemistry and biophysics.
[184] R. Youle,et al. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy , 2008, The Journal of cell biology.
[185] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[186] G. Semenza,et al. HIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells , 2007, Cell.
[187] Johan Auwerx,et al. PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure , 2009, Current opinion in lipidology.
[188] N. Denko,et al. Hypoxia, HIF1 and glucose metabolism in the solid tumour , 2008, Nature Reviews Cancer.
[189] Max S Wicha,et al. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[190] G. Semenza. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. , 2007, The Biochemical journal.
[191] S. Ménard,et al. Identification of Breast Cancer-Restricted Antigens by Antibody Screening of SKBR3 cDNA Library Using a Preselected Patient's Serum , 2002, Breast Cancer Research and Treatment.
[192] Guy C. Brown,et al. Nitric oxide stimulates PC12 cell proliferation via cGMP and inhibits at higher concentrations mainly via energy depletion. , 2006, Nitric oxide : biology and chemistry.
[193] Kjell Hultenby,et al. Mitochondrial transcription factor A regulates mtDNA copy number in mammals. , 2004, Human molecular genetics.
[194] Gurmit Singh,et al. Mitochondria and Cancer , 2013, BioMed research international.
[195] Jiri Bartek,et al. An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.
[196] Gregory Stephanopoulos,et al. Quantifying Reductive Carboxylation Flux of Glutamine to Lipid in a Brown Adipocyte Cell Line* , 2008, Journal of Biological Chemistry.
[197] E. Wills,et al. An unusual myopathy: Speckled muscle fibers due to enlarged mitochondria , 2007, Muscle & nerve.
[198] J. Vicencio,et al. BH3-Only Proteins and BH3 Mimetics Induce Autophagy by Competitively Disrupting the Interaction between Beclin 1 and Bcl-2/Bcl-XL , 2007, Autophagy.
[199] A. Garnier,et al. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. , 2008, Cardiovascular research.
[200] Eyal Gottlieb,et al. Mitochondrial tumour suppressors: a genetic and biochemical update , 2005, Nature Reviews Cancer.
[201] Yau-Huei Wei,et al. Mitochondrial DNA Instability and Metabolic Shift in Human Cancers , 2009, International journal of molecular sciences.
[202] E. Nisoli,et al. Nitric oxide and mitochondrial biogenesis , 2006, Journal of Cell Science.
[203] G. Semenza,et al. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.
[204] Anthony Mancuso,et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.
[205] Anastasia Kralli,et al. Transcriptional control of mitochondrial biogenesis and function. , 2009, Annual review of physiology.
[206] Å. Fransson,et al. The Miro GTPases: At the heart of the mitochondrial transport machinery , 2009, FEBS letters.
[207] Y. Shimada,et al. Profiles of carbohydrate-metabolizing enzymes in human hepatocellular carcinomas and preneoplastic livers. , 1988, Cancer research.
[208] S. Schreiber,et al. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[209] S. Naylor,et al. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. , 2009, Human molecular genetics.
[210] E. Robin,et al. Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells , 1988, Journal of cellular physiology.
[211] Gary Fiskum,et al. Glutamine metabolism in AS-30D hepatoma cells. Evidence for its conversion into lipids via reductive carboxylation , 1995, Molecular and Cellular Biochemistry.
[212] E. Shoubridge,et al. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease , 1990, Cell.
[213] A. Ortega,et al. A message emerging from development: the repression of mitochondrial β-F1-ATPase expression in cancer , 2007, Journal of bioenergetics and biomembranes.
[214] S. Safe,et al. Hormonal regulation of lactate dehydrogenase-A through activation of protein kinase C pathways in MCF-7 breast cancer cells. , 2004, Biochemical and biophysical research communications.
[215] Robert A. Harris,et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism , 2008, Nature Genetics.
[216] F. de Longueville,et al. CREB activation induced by mitochondrial dysfunction triggers triglyceride accumulation in 3T3-L1 preadipocytes , 2006, Journal of Cell Science.
[217] Jin-Shui Pan,et al. Reactive oxygen species: A double-edged sword in oncogenesis , 2009 .
[218] E. Cadenas,et al. Tumor Cell Phenotype Is Sustained by Selective MAPK Oxidation in Mitochondria , 2008, PloS one.
[219] J. Uriel. Cancer, retrodifferentiation, and the myth of Faust. , 1976, Cancer research.
[220] T. Cotter,et al. Apoptosis and cancer: the genesis of a research field , 2009, Nature Reviews Cancer.
[221] K. Vousden,et al. p53: new roles in metabolism. , 2007, Trends in cell biology.
[222] R. Hill,et al. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. , 2001, Cancer research.
[223] L. Jacobs,et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[224] P. Ježek,et al. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. , 2005, The international journal of biochemistry & cell biology.
[225] S. Dimauro,et al. Myoclonic epilepsy and ragged‐red fibers with cytochrome oxidase deficiency: Neuropathology, biochemistry, and molecular genetics , 1989, Annals of neurology.
[226] K. Hirakawa,et al. Prognostic predictive value of 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer. , 2001, International journal of oncology.
[227] Chi V Dang,et al. Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.
[228] M. Sobrinho-Simões,et al. Mitochondria and cancer , 2009, Virchows Archiv.
[229] Zvulun Elazar,et al. ROS, mitochondria and the regulation of autophagy. , 2007, Trends in cell biology.
[230] Peter Vaupel,et al. Tumor microenvironmental physiology and its implications for radiation oncology. , 2004, Seminars in radiation oncology.
[231] P. Leedman,et al. Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. , 2002, The Biochemical journal.
[232] R. Rossignol,et al. Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis. , 2009, Frontiers in bioscience.
[233] Michael D. Cole,et al. Transcription-independent functions of MYC: regulation of translation and DNA replication , 2008, Nature Reviews Molecular Cell Biology.
[234] J R Griffiths,et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.
[235] David E. Misek,et al. The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. , 2004, Carcinogenesis.
[236] E. Espinosa,et al. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. , 2005, Carcinogenesis.
[237] R. McLendon,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[238] Huasheng Lu,et al. Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis* , 2002, The Journal of Biological Chemistry.
[239] P. Hammerman,et al. Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. , 2004, TIBS -Trends in Biochemical Sciences. Regular ed.
[240] R J Hodgkiss,et al. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. , 2000, International journal of radiation oncology, biology, physics.
[241] R. Youle,et al. Role of the Ubiquitin Conjugation System in the Maintenance of Mitochondrial Homeostasis , 2008, Annals of the New York Academy of Sciences.
[242] Jaap Keijer,et al. HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. , 2008, Carcinogenesis.
[243] Yan A. Su,et al. Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy , 2009, Molecular Cancer Therapeutics.
[244] J. Ellison,et al. Clinical and molecular genetics of patients with the Carney–Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD , 2008, European Journal of Human Genetics.
[245] H. Christofk,et al. Pyruvate kinase M2 is a phosphotyrosine-binding protein , 2008, Nature.
[246] P. Navas,et al. Coenzyme Q deficiency triggers mitochondria degradation by mitophagy , 2009, Autophagy.
[247] M. Priault,et al. Impairing the bioenergetic status and the biogenesis of mitochondria triggers mitophagy in yeast , 2005, Cell Death and Differentiation.
[248] C. Thompson,et al. ATP citrate lyase is an important component of cell growth and transformation , 2005, Oncogene.
[249] R. Orlando,et al. Multiple molecular forms of lactate dehydrogenase and glucose 6‐phosphate dehydrogenase in normal and abnormal human breast tissues , 1976, Cancer.
[250] Marta Martínez,et al. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. , 2004, The Biochemical journal.
[251] T. Tsuruo,et al. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy , 2009, British Journal of Cancer.
[252] P. Vaupel,et al. Pyruvate kinase type M2: a crossroad in the tumor metabolome , 2002, British Journal of Nutrition.
[253] D. Klionsky,et al. Mitophagy in Yeast Occurs through a Selective Mechanism* , 2008, Journal of Biological Chemistry.
[254] G. Thomas,et al. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. , 2006, Cell metabolism.
[255] J. Martinou,et al. Mitochondrial dynamics and cancer. , 2009, Seminars in cancer biology.
[256] M. Nikiforova,et al. Diagnostic Use of IDH1/2 Mutation Analysis in Routine Clinical Testing of Formalin-Fixed, Paraffin-Embedded Glioma Tissues , 2009, Journal of neuropathology and experimental neurology.
[257] A. John. Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: the impact of this on the treatment of cancer. , 2001, Medical hypotheses.
[258] R. Burd,et al. Absence of Crabtree effect in human melanoma cells adapted to growth at low pH: reversal by respiratory inhibitors. , 2001, Cancer research.
[259] A. Koong,et al. Loss of PTEN facilitates HIF-1-mediated gene expression. , 2000, Genes & development.
[260] Russell G. Jones,et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. , 2005, Molecular cell.
[261] P. Puigserver,et al. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. , 2006, Cell metabolism.
[262] M. Guppy,et al. Cancer metabolism: facts, fantasy, and fiction. , 2004, Biochemical and biophysical research communications.